Heart failure is a life‐threatening disease and addressing it should be considered a global
health priority. At present, approximately 26 million people worldwide are living with heart …

It is important that the medical profession play a significant role in critically evaluating the
use of diagnostic procedures and therapies as they are introduced and tested in the …

This new edition of Health at a Glance presents the most recent comparable data on the
performance of health systems in OECD countries. Where possible, it also reports data for …

Type 2 diabetes mellitus is a risk factor for incident heart failure and increases the risk of
morbidity and mortality in patients with established disease. Secular trends in the …

Diastolic heart failure (DHF) currently accounts for more than 50% of all heart failure
patients. DHF is also referred to as heart failure with normal left ventricular (LV) ejection …

Major differences between men and women exist in epidemiology, manifestation,
pathophysiology, treatment, and outcome of cardiovascular diseases (CVD), such as …

Atrial fibrillation (AF) is an arrhythmia that can occur as the result of numerous different
pathophysiological processes in the atria. Some aspects of the morphological and …

Background Angiotensin-converting-enzyme (ACE) inhibitors improve outcome of patients
with chronic heart failure (CHF). A substantial proportion of patients, however, experience no …

Aims The ESC‐HF Pilot survey was aimed to describe clinical epidemiology and 1‐year
outcomes of outpatients and inpatients with heart failure (HF). The pilot phase was also …

Late-breaking clinical trials presented at the 2005, 2006, and 2007 annual scientific
meetings of the ACCF, AHA, and European Society of Cardiology, as well as selected other …